The programmed cell death protein-1/programmed cell death ligand 1 expression, CD3+ T cell infiltration, NY-ESO-1 expression, and microsatellite instability phenotype in primary cutaneous melanoma and mucosal melanoma and their clinical significance and prognostic value: a study of 89 consecutive cases-Reference-Cited by-同舟云学术

The programmed cell death protein-1/programmed cell death ligand 1 expression, CD3+ T cell infiltration, NY-ESO-1 expression, and microsatellite instability phenotype in primary cutaneous melanoma and mucosal melanoma and their clinical significance and prognostic value: a study of 89 consecutive cases

Published:2020-02 Issue:1 Volume:30 Page:85-101
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Ren Yu,Lv Qing,Yue Wuheng,Liu Baorui,Zou Zhengyun

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference61 articles.

1. Clinical correlates of NRAS and BRAF mutations in primary human melanoma.;Ellerhorst;Clin Cancer Res,2011

2. Cancer treatment and survivorship statistics, 2014.;DeSantis;CA Cancer J Clin,2014

3. Clinical practice guidelines in oncology: melanoma.;Chinese Clin Oncol,2010

4. C-KIT gene amplification in 262 Chinese melanoma patients.;Li;Chinese Clin Oncol,2010

5. Hallmarks of cancer: the next generation.;Hanahan;Cell,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD-L1, CD4+, and CD8+ Tumor-Infiltrating Lymphocytes (TILs) Expression Profiles in Melanoma Tumor Microenvironment Cells;Journal of Personalized Medicine;2023-01-27

2. Adjuvant Therapy and Prognosticators of Survival in Head and Neck Mucosal Melanoma;The Laryngoscope;2021-08-06

3. Pembrolizumab for advanced cervical cancer: safety and efficacy;Expert Review of Anticancer Therapy;2020-11-26

4. Pathology-based Biomarkers Useful for Clinical Decisions in Melanoma;Archives of Medical Research;2020-11

5. A pooled analysis of the prognostic value of PD-L1 in melanoma: evidence from 1062 patients;Cancer Cell International;2020-03-30